NT ‐proBNP predicts the cardio‐renal response to aliskiren in patients with type 2 diabetes at high renal and cardiovascular risk
Diabetes, Obesity and Metabolism,Volume 0, Issue ja, -Not available-.
Source: Diabetes, Obesity and Metabolism - Category: Endocrinology Authors: Nienke M.A.
Idzerda
,
Frederik
Persson
,
Michelle J.
Pena
,
Barry M.
Brenner
,
Patrick
Brunel
,
Nish
Chaturvedi
,
John J.
McMurray
,
Hans ‐Henrik
Parving
,
Dick
de Zeeuw
,
Hiddo J. L.
Heerspink Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Heart | Obesity | Tekturna